Thaera Arafat

Thaera Arafat

Auto-generated profile, based on publicly available information

Thaera Arafat

Montreal Neurological Institute-Hospital, McGill University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2024 in Epilepsy & Behavior
Verified
Journal Article
Closed access
STShahin Tavakol
Shahin Tavakol
VKValeria Kebets
Valeria Kebets
JRJessica Royer
Jessica Royer
QLQiongling Li
Qiongling Li
HAHans Auer
Hans Auer
BBBoris Bernhardt
Boris Bernhardt

27 September 2022 in Epilepsy & Behavior Reports
Verified
Journal Article
Open access
TAThaera Arafat
Thaera Arafat
GMGadi Miron
Gadi Miron
ISIdo Strauss
Ido Strauss
FFFiras Fahoum
Firas Fahoum
Neurostimulation devices including vagus nerve stimulation (VNS), deep brain stimulation (DBS), and responsive neurostimulation (RNS) are approved therapeutic options for drug resistant epilepsy (DRE). As these devices are increasingly used in clinical practice, it is of importance to recognize their artifacts in electrodiagnostic studies. This is a retrospective study of all adult DRE patients treated with neuromodulation devices for epilepsy at our center between 2012 and 2021. Available EEGs were reviewed for neurostimulator-related artifacts. Fifty-two patients were included. 37% of patients had neurostimulation related electrophysiological artifacts (20% of VNS, 75% of DBS, all patients with dual VNS-DBS treatment, and in the single patient with RNS). Artifacts were intermittent, appearing most commonly simultaenously in the EEG and ECG. VNS artifacts were monomorphic appearing mostly in the lower temporal EEG electrodes, whereas DBS artifacts were with variable morphology, amplitude, and scalp distribution. At times, the artifacts resembled electrographic seizures in the EEG and mimicked extrasystole or asystole in the ECG. With the increasing use of neurostimulation treatments for DRE, and the need for frequent electrodiagnostic studies in this patient population, it is important clinicians recognize these electrophysiological findings as artifacts, to avoid misdiagnosis and facilitate accurate interpretation.

26 November 2025 in Clinical Neurophysiology
Verified
Journal Article
Open access
TAThaera Arafat
Thaera Arafat
ZCZhengchen Cai
Zhengchen Cai
JGJean Gotman
Jean Gotman
Simultaneous EEG-fMRI is a unique, noninvasive neuroimaging technique that enables high spatial resolution mapping of metabolic changes linked to EEG epileptic discharges in focal and generalized epilepsy, reflected through fMRI signals. It is increasingly recognized as a valuable tool in the presurgical evaluation of drug-resistant epilepsy, supporting the localization of epileptogenic zones, guiding electrode implantation, and informing surgical strategies and outcome prediction, while also revealing important insights into the networks involved in epileptic activity. Advances in artifact removal, automated spike detection, and statistical modeling have improved EEG-fMRI's data quality and clinical utility. It is particularly valuable in diagnostically challenging cases where standard EEG is not localizing, or MRI findings are negative. However, its routine clinical adoption is limited by the complexity of the procedure, the lack of standardized protocols, interpretation criteria, and broader validation across diverse epilepsy populations. This review highlights EEG-fMRI's evolving role in localizing epileptic discharges, emphasizing both methodological and clinical aspects. It covers the process from data acquisition through analysis to statistical interpretation and decision-making, with its application in distinguishing generalized from widespread activity, assessing thalamic involvement in focal epilepsy, evaluating status epilepticus, mapping blood oxygen-level dependent responses in relation to structural lesions, and supporting presurgical planning in complex cases, demonstrating its potential to improve diagnostic precision and treatment outcomes.

18 May 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
RCRaul Rodriguez Cruces
Raul Rodriguez Cruces
JLJack Lam
Jack Lam
TAThaera Arafat
Thaera Arafat
JRJessica Royer
Jessica Royer
JCJudy Chen
Judy Chen
BBBoris C. Bernhardt
Boris C. Bernhardt
Temporal lobe epilepsy (TLE), the most common pharmaco-resistant epilepsy in adults, has been linked to structural brain changes extending beyond the mesiotemporal areas. While not traditionally viewed as a neurodegenerative disorder, recent ex-vivo studies have shown elevated levels of misfolded tau protein in TLE. This study investigated tau deposition in TLE patients using the in-vivo PET tracer [18F]MK-6240. We studied 28 TLE patients and 28 healthy controls to assess tau uptake and its relationship with brain connectivity, clinical variables, and cognitive function alongside post-surgical tissue from a subset of patients. Compared to controls, TLE patients exhibited markedly increased [18F]MK-6240 uptake in bilateral superior and medial temporal regions and the parietal cortex, with tau accumulation following regional functional and structural connectivity and cognitive impairment. Immunohistochemistry analysis confirmed variable phosphorylated tau staining in 5/6 operated cases with available specimens. These findings suggest that tau accumulation contributes to cognitive decline observed in TLE, supporting a potential role of tau in epilepsy-related neurodegeneration.

1 December 2025 in bioRxiv
Verified
Preprint
Open access
DCDonna Gift Cabalo
Donna Gift Cabalo
JDJordan DeKraker
Jordan DeKraker
KXKe Xie
Ke Xie
TAThaera Arafat
Thaera Arafat
JRJessica Royer
Jessica Royer
BBBoris C. Bernhardt
Boris C. Bernhardt
Declarative memory deficits represent considerable challenges to adequate functioning and wellbeing in temporal lobe epilepsy (TLE) and frontal lobe epilepsy (FLE), two of the most common pharmaco-resistant epilepsies. TLE and FLE are impacted differently however, with TLE affecting primarily episodic, and mildly semantic memory, while FLE presenting with overall lesser declarative impairments and a greater involvement of language processes. Although functional magnetic resonance imaging (fMRI) studies are overall compatible with differential disruptions of medial temporal and fronto-limbic networks in both syndromes, direct comparisons of brain activity and connectivity remain scarce. The current study investigated how alterations in intrinsic functional brain organization, as mapped with resting-state connectivity (rsFC), shapes altered brain network activations in both episodic and semantic memory states. To this end, we acquired task- and rs-fMRI data in 28 TLE patients and 17 FLE patients and 87 age- and sex-matched healthy controls (HCs). We used activity flow mapping (AFM), a generative machine learning technique that derives plausible task activation patterns via individualized rsFC as well as normative task activation data. Previous studies in HC as well as patient populations have shown that this technique has been effective in identifying mechanisms contributing to atypical functional organization across different context. Overall, AFM reliably predicted task activations across HC, TLE, and FLE, but prediction accuracy was consistently reduced in both patient groups, indicating impaired propagation of task-relevant signals. These reductions co-occurred with abnormal episodic and semantic task activation patterns, atypical rsFC, and behavioral profiles marked by preserved semantic but impaired episodic memory performance in both patient groups. Importantly, although neither task-evoked abnormalities nor rsFC disruptions alone were associated with clinical variables, lower AFM accuracy in patients robustly tracked poorer episodic and semantic memory performance and longer disease duration. Prediction accuracy was driven more by intrinsic functional than structural network features, suggesting that altered network communication, rather than gross anatomy, constrains AFM in pharmaco-resistant epilepsy. Our work revealed syndrome-specific yet convergent disruptions in paralimbic and heteromodal association systems, linking intrinsic dysconnectivity to a shared episodic vulnerability and semantic resilience across TLE and FLE. By modelling how intrinsic connectivity shapes task-evoked responses, AFM provides a mechanistic account of imbalanced memory-state activations and isolates network-flow pathways as targets for intervention and rehabilitation.

14 June 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
JLJack Lam
Jack Lam
RRRaúl Rodriguez-Cruces
Raúl Rodriguez-Cruces
TAThaera Arafat
Thaera Arafat
JRJessica Royer
Jessica Royer
JCJudy Chen
Judy Chen
BBBoris Bernhardt
Boris Bernhardt
Tauopathies are pathologies wherein phosphorylated insoluble tau aggregates in neurons, leading to dysfunction and degeneration. Positron emission tomography (PET) enables measurement of in vivo tau, with second-generation radiotracers such as [ 18 F]MK6240 showing high tau affinity with minimal off-target binding. While tauopathies are commonly linked to age-related neurodegenerative diseases, notably Alzheimer’s disease (AD), evidence suggests pathophysiological cascades may begin long before clinical onset. Increasingly, tau is recognized in pathologies affecting younger individuals, including autosomal dominant AD, Niemann-Pick disease type C, chronic traumatic encephalopathy, and epilepsy, thus highlighting the importance of normative data in non-geriatric populations. Here, we present a dataset of 33 young to middle-age healthy adults (mean age 34.0±10.4 years, 12 female) with [ 18 F]MK6240 PET data and T1w magnetic resonance imaging. Longitudinal data are also available in a subset of 9 participants with a minimum follow-up time of 1 year. Our dataset aims to support imaging biomarker studies on younger individuals potentially at risk for AD and to advance work in tauopathies affecting non-geriatric populations generally excluded from neurodegeneration studies.